Assa

Quick links to important sections

Assa

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Assa

Quick Facts

Property Description
Active Ingredient Acetylsalicylic Acid (ASA)
Form Solid oral tablet (often enteric-coated)
Pharmacological Class Nonsteroidal Anti-Inflammatory Drug (NSAID) and Antiplatelet Agent
Common Use Relief of minor pain and fever; maintenance of blood fluidity
Origin Synthetic compound (Salicylate derivative)

Assa: The Dual Classification of Acetylsalicylic Acid (ASA)

Assa is a widely available trade name for a synthetic pharmaceutical preparation whose sole active component is Acetylsalicylic Acid (ASA), a substance globally recognized for its polyfunctional properties. This medicine is categorized as belonging to two critical pharmacological categories: it functions both as a Nonsteroidal Anti-Inflammatory Drug (NSAID) and an Antiplatelet Agent. The dual classification of Assa is foundational to its utility. Acetylsalicylic Acid acts as an NSAID by blocking the production of chemical messengers that cause inflammation and pain. This confirms that the medication is effective at inhibiting processes that lead to inflammation and symptomatic discomfort.

The active component, Acetylsalicylic Acid, is a synthetic derivative of the salicylate class, ensuring consistent purity and potency. Its mechanism is recognized across its diverse applications, distinguishing it from non-salicylate analgesics. Its unique mechanism of irreversible platelet inhibition sets it apart from common reversible NSAIDs, defining its essential role in preventing the undesired formation of internal blood clots.

Form and General Purpose: Addressing Pain, Fever, and Platelet Function

Assa is typically manufactured as a solid oral dosage form, most commonly an enteric-coated tablet, designed for consumption via the oral route of administration. This special coating is a technical feature intended to shield the active ingredient from stomach acid before absorption, a formulation choice often associated with long-term regimens (a differentiating factor from standard uncoated Aspirin).

The medicine's general purpose directly reflects its potent dual-action profile. Assa provides comprehensive symptomatic relief by helping to alleviate minor aches and pains and rapidly reduce elevated body temperature. Concurrently, its antiplatelet function supports blood fluidity, thereby contributing to the maintenance of healthy circulation. This combination of effects establishes Acetylsalicylic Acid as an Essential Medicine for both acute discomfort and long-term circulatory needs. A primary benefit of ASA is its role in regulating platelet aggregation. This verifies the drug's established efficacy in maintaining proper blood flow.

Differentiating Note: Assa is commonly positioned for patients requiring consistent low-dose anti-aggregant therapy, highlighting the precision and sustained delivery enabled by its coated tablet form.

Regulatory References

  1. Salicylic Acid (Aspirin) - StatPearls - NCBI Bookshelf

What side effects are possible with Assa?

Possible Side Effects and Safety Information

Assa (Acetylsalicylic Acid/ASA) has an official safety profile defined by regulatory agencies based on its action as an NSAID and an antiplatelet agent. This profile categorizes adverse reactions and outlines specific safety restrictions.

Frequency-Classified Adverse Reactions

The frequency of side effects is formally categorized in regulatory documents:

Classification Examples of Documented Effects
Common (1%–10%) Increased bleeding tendencies, Dyspepsia (indigestion).
Uncommon (0.1%–1%) Urticaria (hives).
Rare (0.01%–0.1%) Anaphylactic reactions, Severe skin reactions, Aplastic anemia.

Other effects include tinnitus (ringing in the ears), nausea, and vomiting, which are reported within official System-Organ-Class groupings.

Documented Serious Adverse Reactions

Government regulatory sources highlight specific serious risks, often requiring explicit warnings:

  • Gastrointestinal Bleeding, Ulceration, and Perforation: This is considered a critical risk that can occur without prior symptoms and may be fatal.
  • Intracranial Hemorrhage: Risk of bleeding in the brain is documented.
  • Reye’s Syndrome: A rare but severe and potentially fatal condition linked to ASA use in children and teenagers recovering from viral illnesses (e.g., flu, chickenpox).
  • Severe Organ Dysfunction: Includes severe hepatic (liver) and renal (kidney) failure.

Population-Specific Restrictions and Limitations

The use of Assa is strictly limited by regulatory contraindications in certain populations:

  • Pediatrics: Use in children and teenagers is restricted due to the specific risk of Reye’s Syndrome when fever or pain is associated with a viral infection.
  • Pregnancy: Contraindicated during the third trimester due to serious documented risks to the fetus.
  • Severe Impairment: Contraindicated in individuals with severe hepatic or renal insufficiency.
  • Hypersensitivity: Contraindicated in patients with a known allergy to NSAIDs or salicylates, or a history of asthma, rhinitis, and nasal polyps induced by NSAIDs.

The official documentation also notes that the risk of serious GI events is higher with prolonged therapy and increased doses. The consumption of three or more alcoholic drinks daily is specifically linked in the label to an increased risk of stomach bleeding.

Overdose and Emergency Response

Overdose and when to seek help

The official overdose information for Assa (Acetylsalicylic Acid/ASA) defines specific manifestations and mandates immediate emergency actions.

Documented Overdose Manifestations

Overdose may initially present with mild symptoms, including tinnitus (ringing in the ears), hearing impairment, nausea, vomiting, and hyperventilation. Severe toxicity is documented by major disturbances in the body's acid-base balance, primarily high anion gap metabolic acidosis, which can rapidly progress to severe complications such as confusion, hyperthermia, seizures, and cardiovascular collapse.

Official Emergency Action

Government regulatory sources mandate that a patient with real or suspected overdose must seek immediate medical attention or contact a Poison Control Center immediately. Urgent medical evaluation is required if any signs or symptoms of toxicity are present, or if acute ingestion levels meet defined high-risk thresholds (≥ 150 mg/kg or ≥ 6.5 g). Children and older adults are noted in official labeling as being particularly susceptible to severe metabolic consequences.

Supportive Procedures and Antidote Status

No specific antidote is known for this toxicity; therefore, management focuses on supportive care and enhanced elimination. Documented procedures include the use of activated charcoal, aggressive fluid replacement, and the use of intravenous sodium bicarbonate to correct acidosis. For severe, life-threatening cases, hemodialysis is an officially described procedure to remove the substance from the body.

Therapeutic Uses of Assa

The therapeutic relevance of Assa (Acetylsalicylic Acid/ASA) is aligned with two primary categories of patient needs.

Support for Cardiovascular and Symptomatic Relief

Assa is commonly used across clinical settings involving an increased risk of severe circulatory events, such as subsequent heart attacks or ischemic strokes. The medication is considered relevant in situations requiring long-term, supportive management to help maintain blood fluidity. It is also applied in contexts where short-term symptomatic assistance is needed to address symptom clusters that may appear suddenly, including mild to moderate headaches, muscular aches, and dental pain. Assa is relevant for specific systemic inflammatory conditions like Rheumatoid Arthritis and certain acute inflammatory syndromes. The primary benefit of the treatment is helping patients cope more steadily with difficult episodes and supporting general comfort during periods of heightened symptoms.


Therapeutic Support Summary

Symptom Domain Key Use / Benefit
Pain & Fever Helps manage symptoms of elevated body temperature and mild physical discomfort.
Circulatory Risk Supports blood fluidity to assist in easing the overall burden of recurrent vascular incidents.
Inflammation Contributes to improved comfort during symptomatic periods of specific inflammatory conditions.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Official Eligibility and Contraindications for Assa (Aspirin)

Official regulatory documents strictly define who may use Assa based on pre-existing conditions and population vulnerabilities. Use is contraindicated (must not be used) in patients with known hypersensitivity to salicylates/NSAIDs, active peptic ulcer disease, hemorrhagic disorders, or severe hepatic (liver) or severe renal (kidney) failure.

Population/Condition Eligibility Status (Regulatory Basis)
Children/Teenagers Contraindicated/Not Recommended for viral illness (risk of Reye's Syndrome).
Third Trimester Pregnancy Contraindicated/Avoid (Risk of fetal harm after sim 20 weeks gestation).
Severe Organ Impairment Contraindicated (Severe liver or kidney disease).
Active Bleeding Contraindicated (Active pathological bleeding, e.g., ulcer or hemorrhage).

Use requires special caution or medical supervision for adults age 60 or older due to increased bleeding risk, and for individuals with a history of stomach ulcers, mild organ impairment, or gout. The use of low-dose Assa for specific pregnancy-related conditions is allowed under medical guidance, but general use of regular strength Assa is restricted during pregnancy.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Assa is primarily defined by its effects on drug metabolism and transport, as documented in official regulatory labeling.

Pharmacokinetic and Pharmacodynamic Interactions

Assa is a substrate for the CYP3A4 enzyme and the P-glycoprotein (P-gp) efflux transporter. The co-administration of strong CYP3A4 inhibitors (such as Ketoconazole) or P-gp inhibitors (such as Cyclosporine) is documented to significantly increase Assa's systemic exposure ( AUC), which may necessitate caution.

Conversely, the use of strong CYP3A4 inducers (such as Rifampicin) or P-gp inducers results in a substantial decrease in Assa's exposure, potentially reducing its effectiveness. The herbal supplement St. John's Wort (Hypericum perforatum), a potent inducer of these pathways, is explicitly restricted.

Pharmacodynamically, official labeling notes that combining Assa with other Central Nervous System (CNS) depressants or Serotonergic Agents may result in additive effects, increasing the risk of associated events. Assa is also documented as a weak inhibitor of CYP2C9.

Interaction Constraints

Certain combinations are explicitly contraindicated due to documented severe risks. Co-administration with Antacids that contain aluminum or magnesium requires a timing separation of at least two hours to prevent reduced absorption of Assa. The official profile includes specific notes that interaction severity with strong inhibitors may be more pronounced in patients with severe hepatic impairment.

Mechanism of Action

Assa (Acetylsalicylic Acid) operates through the unique mechanism of irreversible covalent inhibition of the Cyclooxygenase (COX) enzyme system, which defines its dual effect on the TXA2 synthesis pathway and PGE2 synthesis pathway.

Irreversible Suppression of Platelet Activity

The primary mechanism involves the permanent blocking of the COX-1 enzyme within circulating platelets through acetylation of a Serine residue. Since platelets are anuclear, they cannot synthesize new enzyme to replace the inhibited COX-1. This sustained inhibition of TXA2 synthesis impairs platelet aggregation, resulting in prolonged platelet dysfunction.


Modulation of PGE2 in Central and Peripheral Signaling

In non-platelet cells, Assa inhibits both COX-1 and the inducible COX-2, leading to a reduction in the synthesis of Prostaglandin E2 ( PGE2). PGE2 is a critical mediator that increases the sensitivity of peripheral nociceptors and elevates the thermal set point in the hypothalamus of the CNS. By limiting PGE2 signaling in these areas, the mechanism decreases the sensitization of peripheral nociceptors and facilitates the downward adjustment of the hypothalamic thermal set point.

Dosage and Administration Information

The administration of Assa (Acetylsalicylic Acid) is based on the intended application, which determines both the dose and the frequency of intake. The routes for systemic delivery are primarily Oral (via tablet or capsule) and, in specific contexts, Rectal (via suppository).


Administration Protocol and Dosing

The medicine is used in two principal regimens, each with distinct numerical instructions. For chronic antiplatelet therapy, the typical maintenance regimen involves a low dose, ranging from 75 mg to 325 mg, administered once daily. Conversely, for short-term, as-needed symptomatic use, the dose ranges from 300 mg to 650 mg and may be repeated every four to six hours, though the total intake must not exceed 4,000 mg in a 24-hour period.


Specific Handling and Intake Conditions

Proper use involves taking oral dosage forms with a full glass of water, and administration is typically performed with or after food to aid intake. Dosage forms such as enteric-coated tablets or extended-release capsules must be swallowed whole and must not be cut, crushed, or chewed, as this compromises the intended release profile of the medicine. For self-treatment of pain or fever, the duration of use is limited, typically not exceeding 3 to 10 days.


Population Constraints

Assa is generally not suitable for children and adolescents (typically under 16 years) for symptomatic use without specific medical consultation. Furthermore, caution and potential dose consideration are indicated when administering Assa to older adults.

Recent Clinical Evidence

Recent Clinical Evidence Overview

Clinical research regarding compounds derived from Assa (also known as asafetida, Ferula assa-foetida) has primarily focused on investigating its effects on gastrointestinal function and specific metabolic markers.


Research Focus

Research Area Study Type and Findings Focus
Gastrointestinal Limited clinical studies have explored the compound's use in individuals with conditions like constipation-predominant irritable bowel syndrome (IBS-C). The goal was to examine its potential role in modulating symptoms, but the studies were generally small or preliminary.
Metabolic Markers Controlled trials have investigated the compound's effect on specific biochemical parameters in individuals with Type 2 Diabetes Mellitus (T2DM). Findings have focused on monitoring changes in blood lipids (e.g., HDL-C), enzymes (e.g., SGPT), and inflammatory markers over a 90-day period.

Safety and Tolerability Data

Research has documented the compound's tolerability, with some clinical data reporting localized skin reactions (eczema) when the essential oil was applied topically in infants. Due to traditional use patterns and animal data suggesting potential effects on implantation, the compound is generally advised to be avoided during pregnancy and lactation. Cases of severe methemoglobinemia have been reported in children following ingestion, leading to a contraindication for use in pediatric populations.

Key Studies & References

  1. Western herbal medicines in the treatment of irritable bowel syndrome: a systematic review and meta-analysis

Frequently Asked Questions (FAQ)

Common questions about Assa (FAQ)

Q: Is it better to take Assa in the morning or at night?

Regulatory documents state that for chronic therapy, Assa is typically administered once daily. Official product information generally does not specify a superior time of day (morning versus night) for administration. The focus is on consistent daily intake.

Q: What happens if I miss a dose of Assa?

General patient guidance often describes options for missed doses, which usually involve taking the dose when remembered. If it is nearly time for the next scheduled dose, regulatory information typically cautions against taking two doses simultaneously.

Q: What is the difference between primary and secondary prevention when talking about Assa?

Regulatory indications for Assa refer to both primary and secondary prevention. Secondary prevention means reducing the risk of a heart attack or stroke in patients who have already experienced such an event. Primary prevention refers to reducing the risk of a first-time event in certain high-risk patients, where the potential benefits are weighed against possible bleeding risks.

Q: Are there different strengths of Assa available?

Yes, official documents confirm that Assa is available in a range of strengths. Common doses include low-dose tablets, such as 81 mg, and regular-strength tablets, such as 325 mg, which are used for different indicated purposes.

Q: Does Assa affect your ability to drive or operate machinery?

Official information lists potential side effects like dizziness, confusion, or drowsiness which may occur, especially at higher doses or in cases of toxicity. Official warnings suggest that patients should note how the medicine affects them before performing tasks that require mental alertness, such as driving.

Q: What is Assa most commonly prescribed for?

Assa is officially indicated for two main purposes: the temporary relief of mild to moderate pain and fever, and for its antiplatelet effects. This antiplatelet action is used to reduce the risk of death or recurrence in patients with established heart and blood vessel disease.

Q: Is Assa the same as [name of a common similar drug]?

The medicine Assa is the generic drug Acetylsalicylic Acid (ASA). The active ingredient remains the same, regardless of the brand name or commercial presentation.

Q: What are the main differences between Assa and aspirin?

Assa is the generic drug name, which is Acetylsalicylic Acid (ASA). This is the exact same active ingredient found in the commonly known trade name, Aspirin. The products are chemically identical.

Q: Can Assa be taken for pain relief, or is it only for heart conditions?

Official indications show Assa is used for both purposes. It is indicated as an analgesic (for pain) and antipyretic (for fever) in symptomatic use. It is also indicated for its antiplatelet use in various cardiovascular conditions.

Q: How quickly should I expect Assa to start working?

For the relief of pain and fever, the onset of action for immediate-release forms can occur relatively quickly, often within 30 minutes to an hour after administration. The antiplatelet effect, however, involves sustained action on the blood cells.

Q: Are there any foods or supplements that interact with Assa?

Official warnings exist regarding potential interactions with certain herbal supplements, such as ginger, garlic, and ginkgo biloba. There are also official warnings about consuming alcohol, as it can increase the risk of gastrointestinal bleeding when taken with Assa.

Q: Does Assa cause stomach problems like heartburn or ulcers?

Yes, official warnings state that Assa can potentially cause stomach issues. These include indigestion, heartburn, and serious outcomes like ulcers and gastrointestinal bleeding, especially with chronic or high-dose use.

Q: Can people with high blood pressure use Assa?

Official documents mention the use of Assa in patients with high blood pressure (hypertension). The drug’s use in patients with high blood pressure is addressed in official documents, with a note that specific risks may be increased.

Q: What are the most common side effects reported for Assa?

Common side effects reported in official documents include mild stomach upset, indigestion, nausea, and the tendency to bruise or bleed more easily than usual. Serious effects are possible but less common.

Q: Is it possible to have an allergic reaction to Assa?

Yes, regulatory documents include a history of allergic reactions to Assa, other salicylates, or NSAIDs as a contraindication. Taking the medicine with a known allergy carries a risk of a serious reaction, such as anaphylaxis.

Q: If I stop taking Assa, what happens?

The outcome of stopping Assa depends on the reason it was prescribed. For patients taking it long-term for cardiovascular reasons, official warnings indicate that stopping the medicine may be associated with an increased risk of serious cardiovascular events. Therefore, sudden cessation of long-term therapy is generally mentioned as a caution in regulatory materials.

Q: Does Assa affect liver function tests?

Official labeling states that the use of Assa has been associated with elevated hepatic enzymes. This indicates a potential effect on liver function that may be revealed during laboratory testing.

Q: Can I take ibuprofen or other NSAIDs with Assa?

Official warnings advise caution regarding the combination of Assa with ibuprofen and other non-steroidal anti-inflammatory drugs (NSAIDs). Taking them together may increase the risk of gastrointestinal bleeding and may potentially interfere with the heart-protective effects of low-dose Assa.

Q: What is the risk of bleeding associated with Assa?

Official documents clearly state that Assa, even at low doses, increases the risk of bleeding. This includes the risk of serious events such as severe gastrointestinal bleeding and intracranial bleeding (bleeding in the brain) due to its antiplatelet effect.

Q: Are there any documented drug-drug interactions I should be aware of with Assa?

Yes, official documents list interactions with various other medications. These commonly include other anticoagulants (blood thinners), certain medicines for gout, and high-dose other NSAIDs.

Q: Can I take Assa if I have kidney problems?

Official documents list severe kidney disease as a caution or contraindication. Assa may affect renal function, and its use in patients with impaired kidney function requires specific consideration and monitoring.

Q: What does the official drug information say about using Assa during pregnancy?

Official labeling generally advises that Assa should be avoided in the third trimester of pregnancy. It is also advised against after 20 weeks of gestation, unless specifically directed by a healthcare professional, due to potential risks to the fetus.

Q: Is Assa safe to use while breastfeeding?

Regulatory documents advise caution or generally do not recommend the use of Assa while breastfeeding. The official warnings note that the medicine is known to pass into breast milk.

Q: What's the difference between a prescription for Assa and an over-the-counter version?

Assa is legally available as both non-prescription (OTC) and prescription (Rx) strength. The prescription status often applies to higher strengths or specific combination products, while lower strengths may be available OTC for symptomatic use.

Q: What does the research say about the long-term use of Assa?

Official documents describe Assa's use in chronic antiplatelet therapy, which is a long-term regimen. This usage is supported by evidence aimed at reducing the risk of secondary cardiovascular events over time.

Q: What should I do if I notice unusual bruising or bleeding while on Assa?

Official patient information describes signs of serious bleeding, such as vomiting blood or black, tarry stools, which regulatory documents emphasize should be reported promptly to a healthcare professional.

Q: Does Assa interact with natural herbal supplements?

Yes, official warnings exist regarding potential interactions with certain herbal supplements (such as ginger, garlic, ginkgo biloba, and feverfew) and with alcohol, which can increase the risk of gastrointestinal bleeding.

Q: Is it normal to feel dizzy or lightheaded when first starting Assa?

Dizziness and lightheadedness are listed among the possible side effects in official drug information. These symptoms should be noted and reported, especially if they are severe or persistent.

Q: What is Assa used for besides cardiovascular issues?

Besides its antiplatelet uses, Assa is officially indicated for its anti-inflammatory effects and to help reduce fever and relieve pain associated with various conditions.

Q: Can Assa affect dental procedures or surgery?

Official warnings state that it is important that a doctor or dentist is aware if Assa is being taken. Due to the increased risk of bleeding, official recommendations state that Assa may need to be temporarily discontinued prior to elective surgery or dental procedures.

Q: What is the evidence for using Assa to prevent a first heart attack?

Official documents address its use for primary prevention, noting it is used in certain high-risk patients. This involves a specific consideration of potential benefits against the risks of bleeding for that individual population.

Q: Who is generally advised NOT to use Assa, according to official warnings?

Official contraindications generally include individuals with a known allergy to Assa or other NSAIDs, those with a history of active stomach ulcers or bleeding, and children/adolescents with viral illness due to a rare but serious risk called Reye's syndrome.

Q: How should I store Assa tablets?

Official documents generally recommend storing Assa tablets at room temperature (e.g., 59°F–86°F or 15°C–30°C). They should be kept in a dry place and away from moisture to maintain their stability and effectiveness.

Q: Are weight gain or weight loss listed as a side effect of Assa?

While not frequently listed as common, official documents mention weight gain as a potential sign of fluid retention, which can be associated with the use of NSAIDs. Changes in weight are examples of effects that regulatory guidance suggests discussing with a healthcare professional.

Q: Is Assa considered a long-term or short-term medication?

Assa is officially described for short-term use (for immediate pain or fever relief) and for chronic (long-term) use (for antiplatelet therapy) depending on the patient's condition and the regimen prescribed.

Q: What conditions make someone ineligible to take Assa?

Ineligibility conditions found in official warnings generally include bleeding disorders (e.g., hemophilia), active stomach ulcers, and a history of a severe allergic reaction to the drug or other similar medicines.

Q: Are there any specific lab tests needed while taking Assa?

Official labeling indicates that Assa has been associated with changes in laboratory tests, such as elevated hepatic enzymes and prolonged bleeding time. This suggests that monitoring of specific lab results may be performed, especially with long-term use.

Q: What are the official recommendations for stopping Assa before surgery?

Official warnings advise that Assa should be discontinued prior to elective surgery or dental procedures. This is typically done several days beforehand to minimize the risk of excessive bleeding during and after the procedure.

Q: Does Assa interact with common cold or flu medicines?

Official warnings advise caution when combining Assa with over-the-counter cold and flu medicines. Many of these products contain ingredients that are also NSAIDs, which can increase the risk of side effects, such as gastrointestinal bleeding, if taken together.

Q: Is it necessary to avoid certain activities while taking Assa?

Due to the potential increased risk of bleeding, particularly internal bleeding, official information suggests considering caution with activities that carry a high risk of injury or trauma. Care should be taken to avoid accidental cuts or injuries.

Q: What does the scientific evidence show regarding the main benefits of Assa?

Official documents summarize evidence demonstrating the drug's benefits in reducing the risk of serious cardiovascular events like heart attack and stroke. It also shows evidence of its effectiveness in reducing pain and fever.

Q: Is Assa used in people with diabetes?

Clinical studies and regulatory documents often mention the use of Assa in specific populations, including those with diabetes. It is sometimes used in these patients to help assess and reduce cardiovascular risk.

Q: Can I take Assa if I have a history of ulcers?

Official warnings state that patients with a history of stomach ulcers or bleeding problems should exercise caution or generally avoid Assa. This is due to the known increased risk of severe gastrointestinal bleeding associated with the medicine.

Q: Is Assa known to cause headaches?

Headache is listed among the possible side effects in official drug information. Any new or persistent headache is an effect that regulatory guidance suggests discussing with a healthcare professional.

Q: Does taking Assa affect fertility?

Regulatory documents state that NSAIDs, including Assa, have been associated with reversible infertility in some studies. Official guidance advises considering withdrawal of the drug in women who are having difficulty conceiving.

Q: What are the signs of a serious side effect from Assa?

Signs of a serious side effect listed in patient information include vomiting blood or material that looks like coffee grounds, black or tarry stools, difficulty breathing, or swelling of the face or throat. These require immediate medical attention.

How should Assa be stored and disposed of?

Storage and Disposal of Assa (Acetylsalicylic Acid 75 mg)

The official labeling for Assa mandates specific conditions to maintain product integrity and ensure safety.


Required Storage Conditions

Requirement Condition
Temperature Store not above 25 C or at Controlled Room Temperature (15 C to 30 C).
Protection Store in the original container to protect from light and moisture.
Child Safety Mandatory to keep the product out of the sight and reach of children.

Disposal Instructions

Unused or expired Assa tablets must not be thrown away with household waste or disposed of in wastewater. Regulatory instructions require consulting a pharmacist for guidance on proper disposal, which typically involves collection at an approved pharmaceutical waste facility.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Assa found in:

A-Z Index: